Quadrant Capital Group’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,595
| Closed | -$124K | – | 2340 |
|
|
2026
Q1 | $124K | Buy |
7,595
+200
| +3% | +$3.13K | ﹤0.01% | 1417 |
|
|
2025
Q4 | $110K | Buy |
7,395
+121
| +2% | +$1.71K | ﹤0.01% | 1473 |
|
|
2025
Q3 | $93.4K | Buy |
+7,274
| New | +$96.9K | ﹤0.01% | 1484 |
|
|
2025
Q2 | – | Sell |
-7,959
| Closed | -$133K | – | 2388 |
|
|
2025
Q1 | $133K | Buy |
7,959
+6,046
| +316% | +$111K | ﹤0.01% | 1452 |
|
|
2024
Q4 | $36.1K | Sell |
1,913
-1,638
| -46% | -$31.6K | ﹤0.01% | 1594 |
|
|
2024
Q3 | $66.7K | Buy |
3,551
+956
| +37% | +$18.3K | ﹤0.01% | 1295 |
|
|
2024
Q2 | $49K | Buy |
2,595
+837
| +48% | +$14.3K | ﹤0.01% | 1413 |
|
|
2024
Q1 | $28.6K | Buy |
1,758
+522
| +42% | +$7.64K | ﹤0.01% | 1690 |
|
|
2023
Q4 | $15.7K | Sell |
1,236
-1,869
| -60% | -$23.6K | ﹤0.01% | 1910 |
|
|
2023
Q3 | $42.3K | Sell |
3,105
-262
| -8% | -$4.04K | ﹤0.01% | 1357 |
|
|
2023
Q2 | $57.8K | Sell |
3,367
-497
| -13% | -$7.7K | 0.01% | 1179 |
|
|
2023
Q1 | $53.8K | Buy |
3,864
+1,293
| +50% | +$19K | 0.01% | 1190 |
|
|
2022
Q4 | $34.4K | Buy |
2,571
+253
| +11% | +$3.27K | ﹤0.01% | 1391 |
|
|
2022
Q3 | $28K | Buy |
2,318
+766
| +49% | +$10.9K | ﹤0.01% | 1373 |
|
|
2022
Q2 | $20K | Buy |
1,552
+514
| +50% | +$6.6K | ﹤0.01% | 1315 |
|
|
2022
Q1 | $14K | Buy |
1,038
+1,010
| +3,607% | +$13.3K | ﹤0.01% | 1510 |
|
|
2021
Q4 | $0 | Sell |
28
-26
| -48% | -$444 | ﹤0.01% | 2672 |
|
|
2021
Q3 | $1K | Buy |
54
+2
| +4% | +$40 | ﹤0.01% | 2386 |
|
|
2021
Q2 | $1K | Buy |
52
+6
| +13% | +$125 | ﹤0.01% | 2318 |
|
|
2021
Q1 | $1K | Buy |
46
+18
| +64% | +$295 | ﹤0.01% | 2285 |
|
|
2020
Q4 | $0 | Hold |
28
| – | – | ﹤0.01% | 2369 |
|
|
2020
Q3 | $0 | Sell |
28
-282
| -91% | -$2.78K | ﹤0.01% | 2294 |
|
|
2020
Q2 | $2K | Sell |
310
-119
| -28% | -$986 | ﹤0.01% | 1955 |
|
|
2020
Q1 | $3K | Buy |
429
+23
| +6% | +$273 | ﹤0.01% | 1812 |
|
|
2019
Q4 | $4K | Buy |
406
+16
| +4% | +$172 | ﹤0.01% | 2138 |
|
|
2019
Q3 | $2K | Hold |
390
| – | – | ﹤0.01% | 2123 |
|
|
2019
Q2 | $2K | Buy |
390
+217
| +125% | +$1.72K | ﹤0.01% | 2169 |
|
|
2019
Q1 | $1K | Sell |
173
-183
| -51% | -$1.47K | ﹤0.01% | 2189 |
|
|
2018
Q4 | $2K | Buy |
356
+183
| +106% | +$1.75K | ﹤0.01% | 1939 |
|
|
2018
Q3 | $1K | Hold |
173
| – | – | ﹤0.01% | 2034 |
|
|
2018
Q2 | $1K | Hold |
173
| – | – | ﹤0.01% | 2058 |
|
|
2018
Q1 | $1K | Hold |
173
| – | – | ﹤0.01% | 2045 |
|
|
2017
Q4 | $1K | Hold |
173
| – | – | ﹤0.01% | 1994 |
|
|
2017
Q3 | $1K | Hold |
173
| – | – | ﹤0.01% | 2011 |
|
|
2017
Q2 | $0 | Hold |
173
| – | – | ﹤0.01% | 2033 |
|
|
2017
Q1 | $1K | Hold |
173
| – | – | ﹤0.01% | 1870 |
|
|
2016
Q4 | $1K | Buy |
+173
| New | +$1.2K | ﹤0.01% | 1787 |
|
|
2016
Q3 | – | Sell |
-163
| Closed | – | – | 2066 |
|
|
2016
Q2 | $0 | Buy |
+163
| New | +$1.08K | ﹤0.01% | 2067 |
|
Other funds holding SEM
GCL
AA
DAM
Quadrant Capital Group's SEM Position: Q2 2026 in Review
Quadrant Capital Group sold out of Select Medical (SEM) in Q2 2026, closing a stake of 7,595 shares — an estimated $124K sold.
Quadrant Capital Group first reported a position in SEM in Q2 2016 and held it in 38 quarters. The position peaked at $133K in Q1 2025. 240 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- Quadrant Capital Group reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 7,595 Select Medical shares in Q2 2026, an estimated $124K.
- Quadrant Capital Group first reported a position in Select Medical in Q2 2016 and held it in 38 quarters.
- Quadrant Capital Group's Select Medical position peaked at $133K in Q1 2025.
- 240 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.